A month of insights: Key takeaways from May’s conferences
June 23, 2025 | Conferences, Innovation, clinical trials, patient engagement
Explore key insights from some of May’s top healthcare conferences, covering patient engagement, health equity, co-creation, and tech innovation shaping clinical trials.
May is always a whirlwind for our team, packed with opportunities to connect, learn, and share at some of the most impactful clinical trial and patient-focused conferences of the year. It’s a month where big ideas take centre stage; from technological innovation to patient-centric trial design, critical topics that shape the future of healthcare. Below, we’ve captured some highlights from four conferences that left us feeling inspired.
Transforming engagement at the Measuring Patient Engagement Summit, Boston
The Measuring Patient Engagement Summit offered a valuable space to explore how we can reshape engagement in healthcare. A common thread emerged throughout discussions: engagement must be “transformational, not just transactional.”
The summit showcased real-world initiatives driving change, refining trial protocols, and sparking informed conversations between patients and providers. However, true progress involves more than just patients; it calls for improved healthcare professional education, stronger caregiver support, and wider care team collaboration.
Amid the discussions about defining and measuring success, one point stood out: human stories and real-world impact matter just as much as the numbers.
– Scott Palmer, Principal Patient Writer
Championing equity at MAPS 2025 EMEA meeting, London
Patient engagement and health equity were standout themes at MAPS EMEA 2025, signalling a powerful shift in how Medical Affairs drives impact. The event highlighted a shift toward embedding real patient voices early and consistently, moving far beyond tokenism.
A drive for embedding real patient voices early and consistently to shape strategy, foster trust, and improve outcomes underpinned several of the impactful and thought-provoking workshops. As did the challenge to tackle the systemic barriers that create health inequities — it’s time to understand more fully the social determinants at play and design inclusive, community-focused approaches!
The message was clear and loud. We must listen deeply, collaborate widely, and learn continuously. Which, for those of us in patient engagement, is our rallying cry!
– Stacey Davidson, Head of Content and Strategy
Redefining co-creation at Patients as Partners EU, London
This year, Patients as Partners Europe asked not “why” but “how” we can better involve patients.
Conversations went beyond surface-level engagement, urging accountability and deeper co-creation. A key takeaway was this call to action: “Start with a blank sheet of paper and ask, ‘What are we trying to do?’” It’s a challenge to focus on people over processes.
Whether revamping trial designs or embedding patient voices consistently, the underlying theme was clear. Patients are co-owners of this process, not guests. The urgency and honesty shared across the event were compelling calls to transform intent into tangible impact.
– Sonal Patel, Content Director
Innovation and empathy at Global Clinical Trials Connect, London
At the Global Clinical Trials Connect conference, new technologies and an emphasis on participant needs are reshaping trial designs.
Artificial intelligence (AI) was a major focus, revolutionising tasks like site selection, eligibility checks, and recruitment. A statistic shared during the event highlighted the potential impact of AI; 85% of patients invited to trials via their GP agree to share records, drastically reducing pre-screening workloads.
Still, technology isn’t the only key to progress. Empathy remains essential, with innovations like accessible ePRO interfaces and real-time participant feedback breaking barriers and expanding opportunities for patients to access life-changing care. These advancements underscore that impactful trials rely on both innovation and humanity.
– Katie Breen, Senior Patient Writer
May’s conferences were more than learning opportunities; they challenged us to rethink and reshape what’s possible. Across every event, one message was clear and inspiring: listen to patients, collaborate meaningfully, and push healthcare forward with empathy and innovation.
This content was provided by Cuttsy + Cuttsy
Company Details
Latest Content from Cuttsy + Cuttsy
Invited, but not equipped: patient involvement needs more than an open door
Explore how pharma can help patients and patient organisations prepare for meaningful involvement in EU HTA without shaping their contribution.
The outcomes are already chosen. So when can patients really shape them?
Explore why involving patients early in Joint Scientific Consultations is critical to shaping the outcomes measured in clinical trials.
Long-term clinical trial engagement is a behavioural challenge – not just an informational one
Explore why long-term clinical trial engagement is a behavioural challenge, showing how proactive support from site teams can help participants stay connected, confident and committed throughout a study.
Patients are telling the truth — just not to you
Patients are often most honest outside the clinic—revealing vital insights that can help clinical trial teams build trust, improve participation and collect better data.
When what matters to patients is hard to measure
Patient-relevant outcomes sit at the heart of the EU HTA reforms, but ensuring they reflect lived experience requires you to look beyond what traditional clinical endpoints measure.
Permission to pause: making treatment breaks part of the cancer care conversation
Exploring how empathetic, patient-centred communication can make planned treatment breaks easier to discuss as part of cancer care.
A seat at the table: what the EU HTA reforms really ask of patient involvement
The EU HTA reforms give patients a formal role in assessing new medicines, but meaningful involvement requires more than simply offering them a seat at the table.
Why faster trials make participant understanding more important than ever
As clinical trials accelerate, clear, accessible consent is essential to help participants understand, engage with and remain in a study.
Older trial participants reject bad design, not technology
Older trial participants aren’t rejecting digital technology — they’re rejecting poorly designed, inaccessible experiences that make participation harder.
5 key takeaways from the Patient Centricity and Engagement Conference
Key takeaways from the Patient Centricity and Engagement conference, exploring how trust, inclusion and meaningful partnership can help turn patient engagement from intention into action.